AI assistant
Sending…
Sopharma AD — Director's Dealing 2026
Jan 28, 2026
2543_rns_2026-01-28_2d4c52dd-5352-4460-8473-e05718d5afd7.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{0}------------------------------------------------
| a) Name "Donev Investments Holding" AD [For natural persons: the first name and the last name(s).] [For legal persons: full name including legal form as provided for in the register where it is incorporated, if applicable.] 2. Reason for the notification a) Position/status Based on the provisions of art.3, para 1, item 25 of Regulation 596/2014 as a person discharging managerial responsibilities. Ognian Donev is an Executive director and chairman of the Board of directors of "Sopharma" AD and chairman of the Board of directors of "Donev Investments Holding" AD [For persons discharging managerial responsibilities: the position occupied within the issuer, emission allowances market participant/auction platform/auctioneer/auction monitor should be indicated, e.g. CEO, CFO.] [For persons closely associated, -An indication that the notification concerns a person closely associated with a person discharging managerial responsibilities; - Name and position of the relevant person discharging managerial responsibilities.] Initial notification b) Initial notification/ Amendment [Indication that this is an initial notification or an amendment to prior notifications. In case of amendment, explain the error that this notification is amending.] 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor "Sopharma" AD a) Name [Full name of the entity.] b) LEI 097900BGGW0000048796 [Legal Entity Identifier code in accordance with ISO 17442 LEI code.] 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial Rights, ISIN № BG4000001264 instrument, type of Indication as to the nature of the instrument instrument Identification code debt instrument; derivative relating to an emission allowance. (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014. b) Nature of the transaction Exercise of rights for issue warrants under Art. 10, point 2f of Delegated Regulation (EU) 2016/522 Commission Delegated Regulation (EU) 2016/522 (1) adopted under Article 19(14) of Regulation (EU) No 596/2014 or a specific example set out in Article 19(7) of Regulation (EU) No 596/2014. c) Price(s) and volume(s) Price(s) volume(s) 0.00 d) Aggregated information Price volume 0.00 [The volumes of multiple transactions are aggregated when these transactions: — Aggregated volume — — relate to the same financial instrument or emission allowance; Price — are of the same nature; — are executed on the same day; and — are executed on the same place of transaction. Using the data standard for quantity, including where applicable the quantity currency, as defined under [Price information: — In case of a single transaction, the price of the single transaction; |
1. | Details of the person discharging managerial responsibilities/person closely associated |
|---|---|---|
| — a share, a debt instrument, a derivative or a financial instrument linked to a share or a | ||
| — an emission allowance, an auction product based on an emission allowance or a | ||
| Instrument identification code as defined under Commission Delegated Regulation supplementing Regulation | ||
| [Description of the transaction type using, where applicable, the type of transaction identified in Article 10 of the | ||
| Pursuant to Article 19(6)(e) of Regulation (EU) No 596/2014, it shall be indicated whether the transaction is | ||
| 217 008 000 | ||
| [Where more than one transaction of the same nature (purchases, sales, lendings, borrows, …) on the same | ||
| Using the data standards for price and quantity, including where applicable the price currency and the quantity | ||
| 217 008 000 | ||
| — In case the volumes of multiple transactions are aggregated: the weighted average price of the aggregated | ||
| 26.01.2026 e) Date of the transaction |
Using the data standard for price, including where applicable the price currency, as defined under Commission |
{1}------------------------------------------------
Current report: № 48/28.01.2026 NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014
Dated: 28.01.2026
| [Date of the particular day of execution of the notified transaction. Using the ISO 8601 date format: YYYY-MM-DD; UTC time.] |
||
|---|---|---|
| f) | Place of the transaction | "Central Depository" AD |
| [Name and code to identify the MiFID trading venue, the systematic internaliser or the organised trading | ||
| if the transaction was not executed on any of the above mentioned venues, please mention 'outside a trading |
More from Sopharma AD
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19
Transaction in Own Shares
2026
May 18
Transaction in Own Shares
2026
May 15
Transaction in Own Shares
2026
May 14